The pharmaceutical industry has been heavily scrutinized in the past for trying to buy and influence the favor of medical professionals like doctors. But now that flat-out bribery has gotten harder to pull off, the industry has found more insidious means of keeping their fingers in the pot: Funding medical research at the university level. Why spend all that time and effort trying to persuade an established healthcare provider, when they can just win the favor of young professionals to-be? Big Pharma’s influence on university medical research simply cannot be ignored — especially when they’re the ones funding most of it.